Harmony Biosciences Holdings
HRMY
Insidertransaktionen und Aktienkurs 2024-2026
Alle Insidertrades bei Harmony Biosciences Holdings
| Datum |
Typ |
Insider |
Position |
Ø-Preis |
Volumen |
|
8.9.2026
|
Verkauf |
Budur, Kumar |
CHIEF MEDICAL OFFICER |
42,7 $ |
1.222.259 $ |
|
4.9.2026
|
Verkauf |
Budur, Kumar |
CHIEF MEDICAL OFFICER |
42,0 $ |
230.911 $ |
|
26.1.2026
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
37,2 $ |
139.171 $ |
|
15.1.2026
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
35,9 $ |
752.833 $ |
|
12.12.2025
|
Verkauf |
Dayno, Jeffrey M. |
PRESIDENT, CEO |
40,1 $ |
1.040.103 $ |
|
5.12.2025
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
39,5 $ |
790.896 $ |
|
21.11.2025
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
35,0 $ |
119.945 $ |
|
15.8.2025
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
36,5 $ |
787.378 $ |
|
1.4.2025
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
32,8 $ |
227.386 $ |
|
3.3.2025
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
32,9 $ |
159.089 $ |
|
27.1.2025
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
38,1 $ |
67.547 $ |
|
27.1.2025
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
38,0 $ |
61.941 $ |
|
24.1.2025
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
37,4 $ |
489.634 $ |
|
21.1.2025
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
40,0 $ |
44.920 $ |
|
21.1.2025
|
Verkauf |
Kapadia, Sandip |
CHIEF FINANCIAL OFFICER |
40,2 $ |
1.004.598 $ |
|
21.1.2025
|
Verkauf |
Dayno, Jeffrey M. |
PRESIDENT, CEO |
40,1 $ |
774.245 $ |
|
16.1.2025
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
37,4 $ |
1.102.795 $ |
|
15.1.2025
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
37,0 $ |
388.841 $ |
|
13.1.2025
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
37,0 $ |
265.946 $ |
|
5.11.2024
|
Verkauf |
Marshman Fund Trust II |
Zehn-Prozent-Eigentümer |
30,3 $ |
18.181.500 $ |
|
5.11.2024
|
Verkauf |
Valor IV Pharma Holdings, LLC |
Zehn-Prozent-Eigentümer |
30,3 $ |
18.181.500 $ |
|
1.11.2024
|
Verkauf |
Marshman Fund Trust II |
Zehn-Prozent-Eigentümer |
30,3 $ |
121.210.000 $ |
|
1.11.2024
|
Verkauf |
Valor IV Pharma Holdings, LLC |
Zehn-Prozent-Eigentümer |
30,3 $ |
121.210.000 $ |
|
29.10.2024
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
40,5 $ |
870.018 $ |
|
3.10.2024
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
35,3 $ |
1.274.546 $ |
|
1.10.2024
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
40,2 $ |
16.077 $ |
|
30.9.2024
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
40,0 $ |
1.434.951 $ |
|
27.9.2024
|
Verkauf |
Dierks, Jeffrey |
CHIEF COMMERCIAL OFFICER |
40,0 $ |
8.009 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Verfolge die Insiderkäufe in Echtzeit per Push in unserem Telegram-Channel.
Jetzt beitreten